Rare syndrome raises transplant cancer risk 5-fold, new study confirms

NCT ID NCT07605884

First seen May 31, 2026 · Last updated Jun 13, 2026 · Updated 2 times

Summary

This study compares 108 children with Denys-Drash syndrome who had a kidney transplant to similar children without the syndrome. The goal is to see if the syndrome increases the risk of a type of cancer called post-transplant lymphoproliferative disorder. Researchers will review medical records from French hospitals to identify risk factors.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DENYS-DRASH SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU Montpellier

    Montpellier, 34000, France

  • CHU de Lille

    Lille, 59000, France

    Contact Email: •••••@•••••

  • CHU de Nancy - Hôpitaux de Brabois

    Nancy, 54500, France

  • Hôpital Femme Mère Enfant, Hospices Civils de Lyon

    Bron, 69500, France

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

  • Hôpital Necker-Enfants Malades

    Paris, 75015, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hôpital Robert Debré

    Paris, 75019, France

    Contact Email: •••••@•••••

  • Hôpital enfants et adolescents, CHU Nantes

    Nantes, 44093, France

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.